LTZ Therapeutics (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- July 30, 2024
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $20,000,000
Company Info
- Founders
- Robert Li, Ph.D.
- Company Description
- LTZ develops novel immunotherapies to treat patients that suffer from cancer and other diseases with an unmet clinical need.
- Market
- Immunotherapy for cancer and autoimmune diseases
- Location
- Redwood City, California, USA
- Coinvestors
- GL Ventures, K2 Venture Partners, Lapam Capital, Shunwei Capital Partners